Novartis entered into agreement to bu... - Advanced Prostate...
Novartis entered into agreement to buy Endocyte, the company with the world license for LU 177 PSMA 617 .
That’s what I was afraid of. I suppose the good news is that those in the know must believe in the efficacy of the product and it’s ability to help PC patients.
Schwah.
The therapy was developed in Heidelberg financed with taxpayer's money. Now the taxpayers will have to pay a fortune to receive this treatment if they get prostate cancer.
This is why new cancer treatments are SO expensive...The first thing Novatris will have to do is recover their $2.1 Billion "investment"..The tiny research company, Endocyte, just made more money than they ever could developing the treatment and marketing it..This is a glaring example why "For Profit" medicine needs to be rained in. Lifesaving drugs and treatments that have been developed at taxpayer expense should never be granted exclusive patents...